Fig. 1.

Heatmap showing lipidomic changes in early- (I/II) and late-stage (III/IV) ovarian cancer patients. In addition, the results are shown in pre- and postmenopausal patients of all stages. The difference is calculated relative to controls. The colour scale (from −70 to 100%) is adjusted according to the lipids, in cancer patients CA 125 showed mean elevation higher than 100%. ***p < 0.001; **p < 0.01; *p < 0.05. Charité study had 60 premenopausal controls and 17 cancer cases as well as 48 postmenopausal controls and 42 cancer cases